Research articleAnti-oxidative effects of SAFRANAL (cas 116-26-7) on immobilization-induced oxidative damage in rat brain
-
Add time:08/26/2019 Source:sciencedirect.com
SAFRANAL (cas 116-26-7), a major constituent of saffron, possesses antioxidant and anti-apoptotic properties showing considerable neuroprotective effects. The present study was designed to investigate the effects of safranal against restraint stress induced oxidative damage in the rat brain. For inducing the chronic restraint stress, rats were kept in the restrainers for 1 h every day, for 21 consecutive days, then, the animals received systemic administrations of vehicle (0.1% DMSO) acted as the control group or safranal daily for 21 days. Results indicated that the rats submitted to restraint stress showed an increase in the immobility time versus the non-stress rats. In addition, stress decreased number of crossing in the rats submitted to restraint stress versus the non-stress animals. Treatment with safranal (0.75 mg/kg) showed a significant reduction in the immobility time compared to the non-treated stress group, while, the treatment improved the number of crossing in rats submitted to restraint stress versus the vehicle-treated stress rats. In the stressed animals that received vehicle, the MDA level was significantly higher and the levels of GSH and antioxidant enzymes were significantly lower than the non-stressed rats. Safranal ameliorated the changes in the stressed animals as compared with the control groups. The present findings indicate that safranal might be effective against depressant-like effects induced by chronic stress via modulating brain oxidative response.
We also recommend Trading Suppliers and Manufacturers of SAFRANAL (cas 116-26-7). Pls Click Website Link as below: cas 116-26-7 suppliers
Prev:SAFRANAL (cas 116-26-7), a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer
Next:Original articleSAFRANAL (cas 116-26-7) epoxide – A potential source for diverse therapeutic applications) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SAFRANAL (cas 116-26-7) and its analogs inhibit Escherichia coli ATP synthase and cell growth08/31/2019
- In-vitro evaluation of antioxidant, anti-elastase, anti-collagenase, anti-hyaluronidase activities of SAFRANAL (cas 116-26-7) and determination of its sun protection factor in skin photoaging08/30/2019
- Original articleThe effects of SAFRANAL (cas 116-26-7), a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations08/29/2019
- Spectroscopic and computational evaluation on the binding of SAFRANAL (cas 116-26-7) with human serum albumin: Role of inner filter effect in fluorescence spectral correction08/28/2019
- Original articleSAFRANAL (cas 116-26-7) epoxide – A potential source for diverse therapeutic applications08/27/2019
- SAFRANAL (cas 116-26-7), a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer08/25/2019
- Modulation of amyloid fibril formation of plasma protein by saffron constituent “SAFRANAL (cas 116-26-7)”: Spectroscopic and imaging analyses08/24/2019
- Experimental and computational investigation on the molecular interactions of SAFRANAL (cas 116-26-7) with bovine serum albumin: Binding and anti-amyloidogenic efficacy of ligand08/23/2019
- Binding of SAFRANAL (cas 116-26-7) to whey proteins in aqueous solution: Combination of headspace solid-phase microextraction/gas chromatography with multi spectroscopic techniques and docking studies08/22/2019